Jiuyuan Gene Declares RMB0.57 Final Dividend per 10 Shares for FY2025; Payment Slated for 30 July 2026

Bulletin Express

04/23

Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Jiuyuan Gene) has announced a final ordinary cash dividend of RMB0.57 per 10 shares (approximately RMB0.057 per share) for the financial year ended 31 December 2025. The distribution was approved by shareholders on 15 June 2026 and will be paid on 30 July 2026.

The dividend timetable is as follows: ex-dividend trading commences on 17 June 2026, the last day to lodge share transfers is 18 June 2026 (16:30), books will be closed from 22 June 2026 to 24 June 2026, and the record date is set for 24 June 2026. Payment details, including the default payout currency and applicable exchange rate for Hong Kong shareholders, will be announced separately.

For overseas non-resident enterprise shareholders—covering all H shares registered in the name of HKSCC Nominees Limited except those held on behalf of investors via H-share full circulation—a 10% enterprise income tax will be withheld and remitted by the company. Further information is provided in the “DIVIDEND TAX” section of the 2025 Annual Report.

Jiuyuan Gene’s issued share capital stands at 241,516,400 shares, excluding 3,882,400 treasury shares; treasury shares are ineligible for the dividend.

The board currently comprises two executive directors (Mr. Fu Hang and Mr. Zhou Wei), four non-executive directors (Mr. Wu Shihang, Mr. Albert Esteve Cruella, Mr. Fei Junjie, and Ms. Yan Weiting), and three independent non-executive directors (Mr. Zhou Zhihui, Ms. Ho Mei Yi, and Dr. Zhou Demin).

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1123642963"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1123642963\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1123642963?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-23 21:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1123642963","market":"us","top_or_hot":-1,"title":"Jiuyuan Gene Declares RMB0.57 Final Dividend per 10 Shares for FY2025; Payment Slated for 30 July 2026","media":"Bulletin Express","content":"<p>Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Jiuyuan Gene) has announced a final ordinary cash dividend of RMB0.57 per 10 shares (approximately RMB0.057 per share) for the financial year ended 31 December 2025. The distribution was approved by shareholders on 15 June 2026 and will be paid on 30 July 2026.</p>\n<p>The dividend timetable is as follows: ex-dividend trading commences on 17 June 2026, the last day to lodge share transfers is 18 June 2026 (16:30), books will be closed from 22 June 2026 to 24 June 2026, and the record date is set for 24 June 2026. Payment details, including the default payout currency and applicable exchange rate for Hong Kong shareholders, will be announced separately.</p>\n<p>For overseas non-resident enterprise shareholders—covering all H shares registered in the name of HKSCC Nominees Limited except those held on behalf of investors via H-share full circulation—a 10% enterprise income tax will be withheld and remitted by the company. Further information is provided in the “DIVIDEND TAX” section of the 2025 Annual Report.</p>\n<p>Jiuyuan Gene’s issued share capital stands at 241,516,400 shares, excluding 3,882,400 treasury shares; treasury shares are ineligible for the dividend.</p>\n<p>The board currently comprises two executive directors (Mr. Fu Hang and Mr. Zhou Wei), four non-executive directors (Mr. Wu Shihang, Mr. Albert Esteve Cruella, Mr. Fei Junjie, and Ms. Yan Weiting), and three independent non-executive directors (Mr. Zhou Zhihui, Ms. Ho Mei Yi, and Dr. Zhou Demin).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jiuyuan Gene Declares RMB0.57 Final Dividend per 10 Shares for FY2025; Payment Slated for 30 July 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJiuyuan Gene Declares RMB0.57 Final Dividend per 10 Shares for FY2025; Payment Slated for 30 July 2026\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-04-23 21:43</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Jiuyuan Gene) has announced a final ordinary cash dividend of RMB0.57 per 10 shares (approximately RMB0.057 per share) for the financial year ended 31 December 2025. The distribution was approved by shareholders on 15 June 2026 and will be paid on 30 July 2026.</p>\n<p>The dividend timetable is as follows: ex-dividend trading commences on 17 June 2026, the last day to lodge share transfers is 18 June 2026 (16:30), books will be closed from 22 June 2026 to 24 June 2026, and the record date is set for 24 June 2026. Payment details, including the default payout currency and applicable exchange rate for Hong Kong shareholders, will be announced separately.</p>\n<p>For overseas non-resident enterprise shareholders—covering all H shares registered in the name of HKSCC Nominees Limited except those held on behalf of investors via H-share full circulation—a 10% enterprise income tax will be withheld and remitted by the company. Further information is provided in the “DIVIDEND TAX” section of the 2025 Annual Report.</p>\n<p>Jiuyuan Gene’s issued share capital stands at 241,516,400 shares, excluding 3,882,400 treasury shares; treasury shares are ineligible for the dividend.</p>\n<p>The board currently comprises two executive directors (Mr. Fu Hang and Mr. Zhou Wei), four non-executive directors (Mr. Wu Shihang, Mr. Albert Esteve Cruella, Mr. Fei Junjie, and Ms. Yan Weiting), and three independent non-executive directors (Mr. Zhou Zhihui, Ms. Ho Mei Yi, and Dr. Zhou Demin).</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02566","symbol_name":"九源基因","start_time":0,"source_url":"","article_id":"1123642963","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1123642963","pubTimestamp":1776951823,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Jiuyuan Gene) has announced a final ordinary cash dividend of RMB0.57 per 10 shares (approximately RMB0.057 per share) for the financial year...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02566":"九源基因"},"translate_title":"玖源基因宣派2025财年末期股息每10股人民币0.57元；预计于2026年7月30日付款","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02566":1},"content_text":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Jiuyuan Gene) has announced a final ordinary cash dividend of RMB0.57 per 10 shares (approximately RMB0.057 per share) for the financial year ended 31 December 2025. The distribution was approved by shareholders on 15 June 2026 and will be paid on 30 July 2026.\nThe dividend timetable is as follows: ex-dividend trading commences on 17 June 2026, the last day to lodge share transfers is 18 June 2026 (16:30), books will be closed from 22 June 2026 to 24 June 2026, and the record date is set for 24 June 2026. Payment details, including the default payout currency and applicable exchange rate for Hong Kong shareholders, will be announced separately.\nFor overseas non-resident enterprise shareholders—covering all H shares registered in the name of HKSCC Nominees Limited except those held on behalf of investors via H-share full circulation—a 10% enterprise income tax will be withheld and remitted by the company. Further information is provided in the 「DIVIDEND TAX」 section of the 2025 Annual Report.\nJiuyuan Gene’s issued share capital stands at 241,516,400 shares, excluding 3,882,400 treasury shares; treasury shares are ineligible for the dividend.\nThe board currently comprises two executive directors (Mr. Fu Hang and Mr. Zhou Wei), four non-executive directors (Mr. Wu Shihang, Mr. Albert Esteve Cruella, Mr. Fei Junjie, and Ms. Yan Weiting), and three independent non-executive directors (Mr. Zhou Zhihui, Ms. Ho Mei Yi, and Dr. Zhou Demin).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}